PRLD   $2.99  -6.27% Market Closed After Close 3.04 1.67%

Prelude Therapeutics Incorporated
Total Cash 179.84M
totalCashPerShare 3.268
EBITDA -140.78M
Total Debt 18.20M
quickRatio 7.707
currentRatio 7.83
Total Revenue
debtToEquity 9.987
Revenue/Share
ROA -0.35222
ROE -0.58449
grossProfits
freeCashflow -56.83M
operatingCashflow -104.11M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -90.66M
forwardPE -0.8741722
floatShares 13.73M
sharesOutstanding 42.17M
sharesShort 2.49M
sharesShortPriorMonth 3.33M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.95%
Short Ratio help_outline 8.15%
shortPercentOfFloat 0.14%
impliedSharesOutstanding
bookValue 3.314
Price To Book help_outline 0.40
earningsQuarterlyGrowth
netIncomeToCommon -129.85M
trailingEps -1.77%
forwardEps -1.51%
enterpriseToEbitda 0.64
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.47 3Q 2024
institutionsCount 95
lastUpdated Nov. 7, 2024, 3:25 a.m.